Pfizer Ltd. — Regulatory Filings 2018

Nov 14, 2018

Pfizer Limited The Capital, 1802 / 1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051 . Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

November 14, 2018

The Corporate Relationship Dept. BSE Limited 1st Floor, P.J.Towers Dalal Street, Fort Mumbai - 400 001 Scrip Code: 500680

Manager, Listing Dept. National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Symbol: PFIZER

Dear Sirs,

Sub: Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulat ions, 2015 Appointment of Mr. Milind Patil as an Executive Director.

Pursuant to regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company has appointed Mr. Milind Patil (DIN: 02546815) as an Additional Director of the Company, designated as Executive Director, Finance with effect from November 14, 2018 for a period of 5 years. The appointment of Mr. Milind Pati l wi ll be subject to the approval of shareholders at the ensuing Annual General Meeting of the Company.

Mr. Milind Patil is a finance professional with over two decades of experience predominantly in the Pharmaceutical industry and having versatile exposure in global MNCs in challenging and complex business environments across multiple finance and business functions. He has a proven track record in business turnaround strategies and managing stakeholders, people, performance and risks and opportunities effectively.

Mr. Milind Patil was appointed as the Chief Financial Officer of the Company effective August 16, 2018. Mr. Patil's last employment was as Chief Financial Officer for Middle East North Africa (MENA) region for Novartis based out of Dubai. Prior to that, he worked as the Country Chief Financial officer (CCFO) for Novartis in India from April, 2011 till March 2016. He has held leadership roles for Siemens, Ciba Geigy, Parke-Davis/Warner-Lambert, Johnson & Johnson.

Mr. Milind Patil is a graduate of commerce and a fellow member of the Institute of Chartered Accountants of India. He has also completed financial excellence program & financial leadership program and advance leadership program from Harvard Business School, USA and Tuck School of Management, USA respectively.

• CIN : L24231 MH1950PLC008311
• ~ contactus.india@pfizer.com
• 0 www.pfizerindia.com

Mr. Milind Patil was awarded the "CA.CFO-healthcare sector award" by the Institute of Chartered Accountants of India in February 2015.

Mr. Milind Patil does not hold any shares in the Company. None of the Directors are related to Mr. Milind Patil. Mr. Milind Patil is not debarred or disqualified from holding the office of Director by virtue of any order from MCA/SEBI or any such statutory authority.

We request you to kindly take the above on record.

Thanking you,

Yours truly, For Pfizer Limited

~,·~ ~kj·e: Nair -

Company Secretary